Dr. Joanna Horobin Made Chief Medical Officer at Verastem.
Verastem appointed Joanna Horobin Chief Medical Officer. Joanna had been President of Syndax Pharmaceuticals, Inc and before that had been Vice President, Oncology at Rhone-Poulenc Rorer (Sanofi, NYSE: SNY), leading the global oncology business. Read more in the Business Wire press release. Verastem is a clinical-stage biopharmaceutical company developing drugs to treat cancer.